Phio Pharmaceuticals (PHIO) Non Operating Income (2016 - 2020)
Historic Non Operating Income for Phio Pharmaceuticals (PHIO) over the last 9 years, with Q3 2020 value amounting to -$3000.0.
- Phio Pharmaceuticals' Non Operating Income fell 11578.95% to -$3000.0 in Q3 2020 from the same period last year, while for Dec 2020 it was -$1000.0, marking a year-over-year decrease of 10126.58%. This contributed to the annual value of -$18000.0 for FY2022, which is 10803.57% down from last year.
- Per Phio Pharmaceuticals' latest filing, its Non Operating Income stood at -$3000.0 for Q3 2020, which was down 11578.95% from -$3000.0 recorded in Q2 2020.
- In the past 5 years, Phio Pharmaceuticals' Non Operating Income ranged from a high of $27000.0 in Q1 2019 and a low of -$11000.0 during Q4 2017
- In the last 5 years, Phio Pharmaceuticals' Non Operating Income had a median value of $4500.0 in 2016 and averaged $6571.4.
- As far as peak fluctuations go, Phio Pharmaceuticals' Non Operating Income surged by 200000.0% in 2019, and later crashed by 11578.95% in 2020.
- Over the past 5 years, Phio Pharmaceuticals' Non Operating Income (Quarter) stood at $4000.0 in 2016, then crashed by 375.0% to -$11000.0 in 2017, then skyrocketed by 163.64% to $7000.0 in 2018, then increased by 28.57% to $9000.0 in 2019, then crashed by 133.33% to -$3000.0 in 2020.
- Its Non Operating Income stands at -$3000.0 for Q3 2020, versus -$3000.0 for Q2 2020 and $5000.0 for Q1 2020.